Market Tracker

03/27 11:41am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

12.69
BATS BZX Real-Time Price
As of 11:37am ET
 -0.09 / -0.70%
Today’s Change
10.85
Today|||52-Week Range
18.48
-10.32%
Year-to-Date

Today’s Trading

Previous close12.78
Today’s open12.71
Day’s range12.60 - 12.96
Volume351,628
Average volume (3 months)1,742,828
Market cap$1.4B
Dividend yield--
Data as of 11:26am ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+25.54%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+0.01+0.09%
ARIAARIAD Pharmaceutical...+0.16+1.96%
NXTMNxStage Medical Inc+0.16+0.95%
SGMOSangamo BioSciences ...+0.48+3.22%
Data as of 11:41am ET, 03/27/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
President, Chief Operating Officer &
Director
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts